AlgometRx

AlgometRx, Inc. is a medical device startup founded in 2015 that specializes in objective pain assessment technology. The company developed the Nociometer®, a platform that analyzes pupil dilation in response to neuroselective stimulation to characterize pain type and intensity. By providing this quantitative data, the technology aims to move pain management away from subjective methods and empirical, trial-and-error prescribing, allowing clinicians to make more informed, personalized treatment decisions for various patient populations.

This technology is designed to address significant gaps in clinical pain management, drug development, and personalized medicine by providing precise monitoring of analgesic impact. The company’s work is intended to help healthcare providers choose appropriate medications and dosages, potentially reducing side effects and misuse. AlgometRx has secured research support, including National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants and funding through the ARPA-H Sprint for Women’s Health, to advance applications for conditions such as pediatric peripheral neuropathy and Lupus.